35 Biggest Movers From Yesterday

Gainers

• CASI Pharmaceuticals, Inc. CASI shares jumped 47.54 percent to close at $6.30 on Tuesday.
• Innovate Biopharmaceuticals, Inc. INNT shares climbed 41.54 percent to close at $46.00 on Tuesday.
• Allena Pharmaceuticals, Inc. ALNA gained 26.17 percent to close at $16.49.
• Cellectis S.A. CLLS shares climbed 25.38 percent to close at $38.53. Cellectis and Allogene Therapeutics intends to continue strategic cancer immunotherapy partnership which originally consisted of Pfizer and Cellectis.
• Bio-Path Holdings Inc BPTH shares surged 24.86 percent to close at $2.21 on Tuesday. Bio-Path reported FY17 loss of $0.80 per share.
• UroGen Pharma Ltd. URGN jumped 23.68 percent to close at $59.80 after the company reported presentation of results from interim analysis of pivotal Phase 3 OLYMPUS trial of UGN-101 (MitoGel™) for non-surgical treatment of upper tract urothelial cancer.
• Myomo, Inc. MYO shares rose 21.33 percent to close at $3.47.
• Vaxart, Inc. VXRT gained 18.11 percent to close at $6.00 on Tuesday.
• Libbey Inc. LBY shares jumped 16.67 percent to close at $5.60.
• Seven Stars Cloud Group, Inc. SSC shares rose 15.77 percent to close at $3.01.
• Galmed Pharmaceuticals Ltd. GLMD climbed 15.08 percent to close at $5.80. Galmed Pharmaceuticals priced its 1 million share offering at $6 per share.
• Marrone Bio Innovations, Inc. MBII jumped 14.22 percent to close at $2.49.
• Zynerba Pharmaceuticals, Inc. ZYNE gained 14.16 percent to close at $9.11 on Tuesday.
• Sunlands Online Education Group STG shares surged 13.74 percent to close at $8.36.
• Spotify Technology S.A. SPOT rose 12.89 percent to close at $149.01. Guggenheim initiated coverage on Spotify Technology with a Buy rating and a $175.00 price target.
• Flexion Therapeutics, Inc. FLXN shares rose 12.61 percent to close at $24.55 on Tuesday.
• eHealth, Inc. EHTH gained 10.22 percent to close at $15.96.
• Social Reality, Inc. SRAX shares climbed 8.44 percent to close at $4.11. Social Reality posted Q4 GAAP earnings of $0.02 per share on gross sales of $6.5 million.
• United Therapeutics Corporation UTHR climbed 7.77 percent to close at $115.77. Credit Suisse upgraded United Therapeutics from Underperform to Neutral.

Losers

• Longfin Corp. LFIN shares declined 30.89 percent to close at $9.89 on Tuesday following investigation by the U.S. Securities and Exchange Commission. Longfin posted a FY17 net loss of $26.4 million on sales of $75 million.
• IZEA, Inc. IZEA shares tumbled 19.33 percent to close at $2.42.
• YogaWorks, Inc. YOGA shares fell 18.4 percent to close at $2.35. YogaWorks posted Q4 adjusted loss of $3.5 million on sales of $14.5 million. The company also issued a weak forecast for the current quarter.
• Nova Lifestyle, Inc. NVFY shares fell 17.4 percent to close at $1.685 on Tuesday.
• Switch, Inc. SWCH shares dipped 15.65 percent to close at $13.37. Switch reported a Q4 loss of $67 million, or $2.09 per share. The company posted revenue of $99.3 million, missing analysts’ estimates of $99.6 million.
• Quest Resource Holding Corporation QRHC shares declined 14.41 percent to close at $1.96 on Tuesday after the company reported downbeat Q4 results.
• Rigel Pharmaceuticals, Inc. RIGL shares dropped 13.6 percent to close at $3.05. Rigel did not achieve primary endpoint for Phase 2 study of fostamatinib In IgA nephropathy.
• SITO Mobile, Ltd. SITO fell 11.58 percent to close at $3.36 on Tuesday after the company filed its Annual Report on Form 10-K for the year ended December 31, 2017.
• Yield10 Bioscience, Inc. YTEN dropped 11.48 percent to close at $1.85.
• Limelight Networks, Inc. LLNW shares fell 11.19 percent to close at $3.89.
• Cronos Group Inc. CRON shares dropped 10.4 percent to close at $5.60.
• Professional Diversity Network, Inc. IPDN shares fell 9.89 percent to close at $2.55 on Tuesday.
• Babcock & Wilcox Enterprises, Inc. BW dropped 9.79 percent to close at $3.87.
• Energous Corporation WATT shares fell 9.5 percent to close at $14.09 on Tuesday.
• Enphase Energy, Inc. ENPH declined 5.99 percent to close at $ 4.24 after announcing a 9.524 million share common stock offering via selling holders.
• PetIQ, Inc. PETQ shares fell 5.2 percent to close at $25.305. PetIQ, Inc. expects FY18 sales of $450 million to $500 million.